✨ Health Notices




4 JUNE 2009 NEW ZEALAND GAZETTE, No. 79 1859

Lester Levy
as chairperson of the board of Waitemata District Health Board.
These appointments will take effect on 5 June 2009 and end on 4 June 2012.
Dated at Wellington this 2nd day of June 2009.

HON TONY RYALL, Minister of Health.

go4588

Medicines Act 1981

Provisional Consent to the Distribution of a Changed Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Thalidomide Pharmion
Active Ingredient: Thalidomide 50mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Penn Pharmaceutical Services Limited, Tredegar, Gwent, United Kingdom

Note: This consent is given subject to the following conditions:

  • Only members of the Royal Australasian College of Physicians may prescribe Thalidomide.
  • Douglas Pharmaceuticals Limited shall manage the risk management programme relating to the distribution and use of thalidomide.

Dated this 2nd day of June 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go4840

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product: Hollywood Nights Pearl Drops (Combination Product)
Active Ingredient: Sodium fluoride 0.221%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: Pharmabroker Sales Limited
Manufacturer: Church & Dwight UK, Folkestone, Kent, United Kingdom

Dated this 2nd day of June 2009.

MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go4841

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the following medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Risperdal Consta
Active Ingredient: Risperidone 25mg
Dosage Form: Vial Powder for injection
Prefilled Syringe Diluent
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alkermes, Wilmington, Ohio, United States of America

Product: Risperdal Consta
Active Ingredient: Risperidone 37.5mg
Dosage Form: Vial Powder for injection
Prefilled syringe Diluent
New Zealand Sponsor: Janssen-Cilag (New Zealand) Limited
Manufacturer: Alkermes, Wilmington, Ohio, United States of America



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2009, No 79





✨ LLM interpretation of page content

πŸ₯ Appointments to the Waitemata District Health Board

πŸ₯ Health & Social Welfare
2 June 2009
Health, District Health Board, Appointment, Waitemata
  • Lester Levy, Appointed chairperson of the board

  • HON TONY RYALL, Minister of Health

πŸ₯ Provisional Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
2 June 2009
Medicines, Consent, Distribution, Thalidomide, Pharmion
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of a New Related Product

πŸ₯ Health & Social Welfare
2 June 2009
Medicines, Consent, Distribution, Toothpaste, Hollywood Nights Pearl Drops
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health

πŸ₯ Consent to the Distribution of a Changed Medicine

πŸ₯ Health & Social Welfare
2 June 2009
Medicines, Consent, Distribution, Risperdal Consta, Risperidone
  • MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health